Week In Review: Insilico Closes $255 Million Round For AI Drug Discovery/Development
June 26, 2021 at 14:22 PM EDT
Insilico Medicine, a Hong Kong company devoted to using AI to speed up drug discovery and R&D, closed a $255 million Series C round led by Warburg Pincus. The company is developing its own products and has formed partnerships with well-known pharmas.
